Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML
Trial ID or NCT#
NCT06561152
Status
RECRUITING
Purpose
To determine the efficacy of the combination of tagraxofusp, cladribine, and cytarabine.
Official Title
Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123-Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Woo In (Yustina) Cho
650-721-2443
View on